Philip H. Coelho, Director at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), sold 216,546 shares at $1.25 ($271K) on 2011-09-06, disclosed to the SEC on 2011-09-07.
Open-market sale of $271k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2021-08-26 | $264K | — | Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |